Cipla Manufacturing Boss To End Innings
This article was originally published in Scrip
Executive Summary
Cipla veteran and technical director Davinder Singh is set to end his innings with the firm, amid speculation that more personnel changes may be in store at the Mumbai-based company.
You may also be interested in...
Cipla Rejigs Deck As Global Head Of Operations Moves On
Cipla’s global head (operations) Raju Subramanyam is leaving the firm to pursue his own ambitions. The exit has resulted in an interesting portfolio rejig at the Mumbai-based firm, known for its generally clear manufacturing compliance record.
Cipla Trimming Jobs Amid Europe Business Rejig
The rumor mill has it that Cipla has begun a significant personnel "rightsizing" effort as it tweaks its business strategy for the next phase of growth. The Indian firm maintains that any job cuts are from natural attrition from its evolving business model in Europe.
IGI Bets On Trispecific Antibody To Make Inroads Into Big Pharma Myeloma Turf
Ichnos Glenmark Innovation’s president and CEO talks to Scrip about the promising activity profile of the alliance’s early stage trispecific antibody versus Janssen’s teclistamab and also maintains that the setback for Gilead’s magrolimab hasn’t eclipsed prospects for its bispecific antibody.